Search Results - "Croockewit, A J"

Splenectomy for the treatment of thrombotic thrombocytopenic purpura by Kappers‐Klunne, M. C., Wijermans, P., Fijnheer, R., Croockewit, A. J., Holt, B., Wolf, J. T. M., Löwenberg, B., Brand, A.

“…Summary Plasma exchange is the treatment of choice for patients with thrombotic thrombocytopenic purpura (TTP) and results in remission in >80% of the cases…”
Get full text

Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study by Vellenga, E., Van Agthoven, M., Croockewit, A. J., Verdonck, L. F., Wijermans, P. J., Van Oers, M. H. J., Volkers, C. P., Van Imhoff, G. W., Kingma, T., Uyl‐de Groot, C. A., Fibbe, W. E.

“…The present study analysed whether autologous peripheral blood stem cell transplantation (PSCT) improves engraftment, quality of life and cost‐effectiveness…”
Get full text

Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options by Amaador, K, Peeters, H, Minnema, M C, Nguyen, T Q, Dendooven, A, Vos, J M I, Croockewit, A J, van de Donk, N W C J, Jacobs, J F M, Wetzels, J F M, Sprangers, B, Abrahams, A C

“…Monoclonal gammopathy of renal significance (MGRS) includes all kidney disorders caused by a monoclonal protein (M-protein) secreted by a small plasma cell…”
Get full text

A European perspective on haematopoietic growth factors in haemato-oncology: Report of an expert meeting of the EORTC by Croockewit, A.J., Bronchud, M.H., Aapro, M.S., Bargetzi, M.J., Crown, J., Gratwohl, A., Lange, W., Ludwig, H., Martinelli, G., Mertelsmann, R., Nuessler, V., Willemze, R., De Witte, T.J.M., Zittoun, R., Zwierzina, H.

Get full text

Immunological responses to adjuvant vaccination with combined CD1c+ myeloid and plasmacytoid dendritic cells in stage III melanoma patients by Bloemendal, Martine, Bol, Kalijn F., Boudewijns, Steve, Gorris, Mark A.J., de Wilt, Johannes H.W., Croockewit, Sandra A.J., van Rossum, Michelle M., de Goede, Anna L., Petry, Katja, Koornstra, Rutger H.T., Figdor, Carl, Gerritsen, Winald R., Schreibelt, Gerty, de Vries, I. Jolanda M.

“…We evaluated the immunological responses of lymph-node involved (stage III) melanoma patients to adjuvant dendritic cell vaccination with subsets of naturally…”
Get full text

Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy? by Croockewit, A J, Koopmans, P P, de Pauw, B E

Get more information

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity by Bol, Kalijn F., Aarntzen, Erik H. J. G., Pots, Jeanette M., Olde Nordkamp, Michel A. M., van de Rakt, Mandy W. M. M., Scharenborg, Nicole M., de Boer, Annemiek J., van Oorschot, Tom G. M., Croockewit, Sandra A. J., Blokx, Willeke A. M., Oyen, Wim J. G., Boerman, Otto C., Mus, Roel D. M., van Rossum, Michelle M., van der Graaf, Chantal A. A., Punt, Cornelis J. A., Adema, Gosse J., Figdor, Carl G., de Vries, I. Jolanda M., Schreibelt, Gerty

“…Dendritic cell (DC)-based immunotherapy is explored worldwide in cancer patients, predominantly with DC matured with pro-inflammatory cytokines and…”
Get full text

The low cycling status of mobilized peripheral blood CD34+ cells is not restricted to the more primitive subfraction by Croockewit, A J, Raymakers, R A, Smeets, M E, vd Bosch, G, Pennings, A H, de Witte, T J

“…Mobilized peripheral blood progenitor cells (PBPC) have been shown to differ qualitatively from bone marrow (BM) progenitors. The released progenitor cells are…”
Get full text

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients by Bol, Kalijn F, Figdor, Carl G, Aarntzen, Erik HJG, Welzen, Marieke EB, van Rossum, Michelle M, Blokx, Willeke AM, van de Rakt, Mandy WMM, Scharenborg, Nicole M, de Boer, Annemiek J, Pots, Jeanette M, olde Nordkamp, Michel AM, van Oorschot, Tom GM, Mus, Roel DM, Croockewit, Sandra AJ, Jacobs, Joannes FM, Schuler, Gerold, Neyns, Bart, Austyn, Jonathan M, Punt, Cornelis JA, Schreibelt, Gerty, de Vries, I Jolanda M

“…Autologous dendritic cell (DC) therapy is an experimental cellular immunotherapy that is safe and immunogenic in patients with advanced melanoma. In an attempt…”
Get full text

The Role of the Different CD34 Epitopes in Detection and Positive Selection of CD34+ Bone Marrow and Peripheral Blood Stem Cells by Croockewit, A J, Raymakers, R A, Preijers, F W, Vierwinden, G, de Witte, T J

“…Positive selection of CD34+ cells is an attractive approach to reduce tumour cell contamination in bone marrow (BM) and peripheral blood progenitor cell (PBPC)…”
Get full text

Bullous lesions of the vulvar region revealing both AL amyloidosis and vulvar carcinoma by Van De Nieuwenhof, H. P., Croockewit, A. J., Van Der Avoort, I. A. M., Bekkers, R. L. M., De Hullu, J. A.

“…We report a patient with a bullous disorder which revealed both AL amyloidosis and a vulvar squamous cell carcinoma. Bullous amyloidosis is the rarest clinical…”
Get full text

Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first‐line treatment in untreated multiple myeloma by Segeren, C. M., Sonneveld, P., Van Der Holt, B., Baars, J. W., Biesma, D. H., Cornellissen, J. J., Croockewit, A. J., Dekker, A. W., Fibbe, W. E., Löwenberg, B., Van Marwijk Kooy, M., Van Oers, M. H. J., Richel, D. J., Schouten, H. C., Vellenga, E., Verhoef, G. E. G., Wijermans, P. W., Wittebol, S., Lokhorst, H. M.

“…We examined the feasibility of achieving a rapid response in patients with previously untreated multiple myeloma by administering vincristine 0.4 mg and…”
Get full text

Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma by SEGEREN, C. M, SONNEVELD, P, VAN MARWIJK KOOY, M, VAN OERS, M. H. J, RICHEL, D. J, SCHOUTEN, H. C, VELLENGA, E, VERHOEF, G. E. G, WIJERMANS, P. W, WITTEBOL, S, LOKHORST, H. M, VAN DER HOLT, B, BAARS, J. W, BIESMA, D. H, CORNELLISSEN, J. J, CROOCKEWIT, A. J, DEKKER, A. W, FIBBE, W. E, LÖWENBERG, B

“…We examined the feasibility of achieving a rapid response in patients with previously untreated multiple myeloma by administering vincristine 0.4 mg and…”
Get full text

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells by Schreibelt, Gerty, Bol, Kalijn F, Westdorp, Harm, Wimmers, Florian, Aarntzen, Erik H J G, Duiveman-de Boer, Tjitske, van de Rakt, Mandy W M M, Scharenborg, Nicole M, de Boer, Annemiek J, Pots, Jeanette M, Olde Nordkamp, Michel A M, van Oorschot, Tom G M, Tel, Jurjen, Winkels, Gregor, Petry, Katja, Blokx, Willeke A M, van Rossum, Michelle M, Welzen, Marieke E B, Mus, Roel D M, Croockewit, Sandra A J, Koornstra, Rutger H T, Jacobs, Joannes F M, Kelderman, Sander, Blank, Christian U, Gerritsen, Winald R, Punt, Cornelis J A, Figdor, Carl G, de Vries, I Jolanda M

“…Thus far, dendritic cell (DC)-based immunotherapy of cancer was primarily based on in vitro-generated monocyte-derived DCs, which require extensive in vitro…”
Get full text

Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial by Sonneveld, Pieter, van der Holt, Bronno, Segeren, Christine M, Vellenga, Edo, Croockewit, Alexandra J, Verhoef, Gregor E.G, Cornelissen, Jan J, Schaafsma, Martijn R, van Oers, Marinus H.J, Wijermans, Pierre W, Westveer, Petra H.M, Lokhorst, Henk M

“…From Erasmus Medical Center Rotterdam (Erasmus MC) and University Medical Center Utrecht (UMCU) for the Dutch-Belgian Hemato-Oncology Cooperative Group…”
Get full text

Rebound of anti-topoisomerase I antibody titres after plasma exchange by Van den Hoogen, F H, Boerbooms, A M, Van de Putte, L B, Verheijen, R, Van Venrooij, W, Croockewit, A J

Get full text

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma by Bol, Kalijn F., MD, van den Bosch, Thomas, MD, PhD, Schreibelt, Gerty, PhD, Mensink, Hanneke W., MD, PhD, Keunen, Jan E.E., MD, PhD, Kiliç, Emine, MD, PhD, Japing, Wouter J., MD, Geul, Kaspar W., MD, Westdorp, Harm, MD, Boudewijns, Steve, MD, Croockewit, Sandra A.J., MD, PhD, van Rossum, Michelle M., MD, PhD, de Goede, Anna L., MD, PhD, Naus, Nicole C., MD, PhD, van der Graaf, Winette T.A., MD, PhD, Gerritsen, Winald R., MD, PhD, de Klein, Annelies, PhD, Punt, Cornelis J.A., MD, PhD, Figdor, Carl G., PhD, Cohen, Victoria M., MD, PhD, Paridaens, Dion, MD, PhD, de Vries, I. Jolanda M., PhD

Get full text

Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study by Segeren, Christine M., Sonneveld, Pieter, van der Holt, Bronno, Vellenga, Edo, Croockewit, Alexandra J., Verhoef, Gregor E.G., Cornelissen, Jan J., Schaafsma, Martijn R., van Oers, Marinus H.J., Wijermans, Pierre W., Fibbe, Wim E., Wittebol, Shulamit, Schouten, Harry C., Kooy, Marinus van Marwijk, Biesma, Douwe H., Baars, Joke W., Slater, Rosalyn, Steijaert, Monique M.C., Buijt, Ivon, Lokhorst, Henk M.

“…We compared the efficacy of intensified chemotherapy followed by myeloablative therapy and autologous stem cell rescue with intensified chemotherapy alone in…”
Get full text

Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life by Vellenga, E, M van Agthoven, Croockewit, A J, Verdonck, L F

Get full text

Oral fluoropyrimidines registered for the treatment of metastatic colorectal carcinoma: a possible gain by Croockewit, A J, de Boer, J E, van Loenhout, J W A, Koopmans, P P

“…Up until now the standard treatment for metastasized colorectal carcinoma has been fluorouracil (5-FU) in combination with folonic acid in low doses…”
Get more information